Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0415 | 0.0415 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0361 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.013 | 0.3223 | 0.3223 |
Brugia malayi | TAR-binding protein | 0.013 | 0.3223 | 0.3223 |
Schistosoma mansoni | tar DNA-binding protein | 0.013 | 0.3223 | 0.3223 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0361 | 1 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0361 | 1 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0035 | 0.0415 | 0.0415 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0889 | 0.0889 |
Onchocerca volvulus | 0.0361 | 1 | 1 | |
Trypanosoma brucei | protein kinase, putative | 0.0361 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0415 | 0.0415 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0361 | 1 | 0.5 |
Giardia lamblia | Kinase, CMGC GSK | 0.0361 | 1 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0361 | 1 | 0.5 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0361 | 1 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0361 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0361 | 1 | 0.5 |
Brugia malayi | RNA binding protein | 0.013 | 0.3223 | 0.3223 |
Echinococcus granulosus | protein kinase shaggy | 0.0361 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0173 | 0.4483 | 0.4483 |
Schistosoma mansoni | tar DNA-binding protein | 0.013 | 0.3223 | 0.3223 |
Loa Loa (eye worm) | RNA binding protein | 0.013 | 0.3223 | 0.3223 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0361 | 1 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.013 | 0.3223 | 0.3223 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.0889 | 0.0889 |
Giardia lamblia | Kinase, CMGC GSK | 0.0361 | 1 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.013 | 0.3223 | 0.3223 |
Echinococcus granulosus | geminin | 0.0173 | 0.4483 | 0.4483 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0361 | 1 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.0361 | 1 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.013 | 0.3223 | 0.3223 |
Loa Loa (eye worm) | TAR-binding protein | 0.013 | 0.3223 | 0.3223 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0361 | 1 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0361 | 1 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.0889 | 0.0889 |
Schistosoma mansoni | tar DNA-binding protein | 0.013 | 0.3223 | 0.3223 |
Echinococcus multilocularis | protein kinase shaggy | 0.0361 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.0889 | 0.0889 |
Echinococcus multilocularis | geminin | 0.0173 | 0.4483 | 0.4483 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0361 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0173 | 0.4483 | 0.4483 |
Echinococcus multilocularis | tar DNA binding protein | 0.013 | 0.3223 | 0.3223 |
Schistosoma mansoni | tar DNA-binding protein | 0.013 | 0.3223 | 0.3223 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0361 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
LD50 (ADMET) | = 10 uM | Cytotoxicity against human BJ cells after 72 hrs by Cell titer-glo assay | ChEMBL. | 21243104 |
LD50 (ADMET) | = 10 uM | Cytotoxicity against human HEK293 cells after 72 hrs by Cell titer-glo assay | ChEMBL. | 21243104 |
LD50 (ADMET) | = 10 uM | Cytotoxicity against human HepG2 cells after 72 hrs by Cell titer-glo assay | ChEMBL. | 21243104 |
LD50 (ADMET) | = 10 uM | Cytotoxicity against human Raji cells after 72 hrs by Cell titer-glo assay | ChEMBL. | 21243104 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.